These collective in vivo studies have yielded conflicting results about the role of PPARβ/δ expression in colon cancer and it is tempting to speculate that differences in the null mouse models could underlie, at least in part, the distinct phenotypes. The gene discussed is PPARD; the disease is colonic neoplasm.